Hill Stephen J. — SEC Form 4 filings
SEC reporting owner CIK 1866154. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-25.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-13 to 2026-08-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 8 filings — 3,796 shares, $63,807 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 1,236 shares @ $23.39 ($28,910) in Lyell Immunopharma, Inc., filed 2026-02-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | Chief Operating Officer | 11 | — | 9 legs · 3,796 sh · $63,807 | 9 |
Form 4 filings — Hill Stephen J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-25 | 4 | Lyell Immunopharma, Inc. (LYEL) | Sale (S): 989 @ $15.54 | EDGAR |
| 2026-08-11 | 4 | Lyell Immunopharma, Inc. (LYEL) | Sale (S): 89 @ $14.34 | EDGAR |
| 2026-06-15 | 4 | Lyell Immunopharma, Inc. (LYEL) | Sale (S): 89 @ $18.92 | EDGAR |
| 2026-02-12 | 4 | Lyell Immunopharma, Inc. (LYEL) | Sale (S): 1,236 @ $23.39 | EDGAR |
| 2026-02-11 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 4,000 @ $0 · Sale (S): 109 @ $23.12 · Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | Lyell Immunopharma, Inc. (LYEL) | Sale (S): 95 @ $16.12 | EDGAR |
| 2025-10-29 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-08-22 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 8,000 @ $0 · Sale (S): 1,004 @ $10.54 | EDGAR |
| 2025-08-13 | 4 | Lyell Immunopharma, Inc. (LYEL) | Sale (S): 91 @ $10.53 · Sale (S): 94 @ $10.34 | EDGAR |
| 2025-02-26 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 112,500 @ $0 · Grant/award (A): 450,000 (derivative) @ $0 · Grant/award (A): 56,250 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | Lyell Immunopharma, Inc. (LYEL) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1866154 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →